首页|miR-628-3p靶向结合STK17B基因对卵巢癌进展的抑制作用

miR-628-3p靶向结合STK17B基因对卵巢癌进展的抑制作用

扫码查看
目的 分析miR-628-3p通过靶向丝氨酸/苏氨酸激酶17B(serine/threonine kinase 17B,STK17B)抑制卵巢癌(ovarian cancer,OV)增殖、迁移和侵袭的能力.方法 生物信息学分析miR-628-3p在OV组织中的表达水平及预后.分别将空载 NC 质粒(miR-NC)、miR-628-3p、miR-628-3p+STK17B 转染至人 OV 细胞 SKOV3 和 HO8910 中,RT-qPCR法检测转染细胞中miR-628-3p表达水平;CCK-8法和克隆试验检测各组细胞增殖能力;划痕愈合试验检测各组细胞迁移能力;Transwell侵袭试验检测各组细胞侵袭能力.裸鼠成瘤试验检测瘤体质量及体积变化.Starbase数据库预测miR-628-3p靶基因,双荧光酶素报告试验进行验证.Western blot法测定各组细胞STK17B蛋白表达水平.结果 miR-628-3p在OV组织中低表达,且患者无病生存期低.与miR-NC组相比,miR-628-3p组SKOV3和HO8910细胞中miR-628-3p表达均上调(t分别为7.789和7.862,P均<0.05),细胞活性(t分别为8.124和8.209,P均<0.05)、数量(t分别为9.012和9.110,P均<0.05)、迁移(t分别为10.002和9.983,P均<0.05)和侵袭(t分别为11.245和11.320,P均<0.05)能力均明显降低.与miR-NC组相比,miR-628-3p组移植瘤体积和质量均明显下降(t分别为8.429和10.367,P均<0.05).数据库预测STK17B为miR-628-3p的靶基因,双荧光酶素报告试验证实,STK17B为miR-628-3p的作用靶点.miR-628-3p组STK17BmRNA和蛋白水平明显低于miR-NC组(mRNA:t分别为13.852和13.914,蛋白:t分别为11.524和11.603,P均<0.05).GEPIA数据分析表明,STK17B在OV组织中高表达.与miR-628-3p组相比,miR-628-3p+STK17B组SKOV3 和 HO8910细胞的活性(t 分别为 8.692 和 8.721,P均<0.05)、数量(t分别为14.112和14.093,P均<0.05)、迁移(t分别为13.805和13.911,P均<0.05)和侵袭(t分别为14.117和14.207,P均<0.05)能力均明显上升.结论 miR-628-3p通过靶向下调STK17B表达水平,抑制OV细胞增殖、迁移和侵袭,从而抑制OV的发展进程.
Inhibitory effect of miR-628-3p on progression of ovarian cancer by targeting STK17B gene
Objective To analyze the ability of miR-628-3p to inhibit the proliferation,migration and invasion of ovarian cancer(OV)by targeting serine/threonine kinase 17B(STK17B).Methods The expression level of miR-628-3p in OV tissues and prognosis were analyzed by bioinformatics.OV cells(SKOV3,HO8910)were transfected with miR-NC(miR-NC group),miR-628-3p(miR-628-3p group)and miR-628-3p+STK17B(miR-628-3p+STK17B group).The expression level of miR-628-3p in OV cells after transfection was determined by RT-qPCR.Cells proliferation ability in each group was measured by CCK-8 and clone assays,the migration ability was detected by scratch assay,and the invasion ability was detected by Transwell invasion assay.The mass and volume of tumors were detected by tumor formation assay in nude mice.The target gene of miR-628-3p was predicted by Starbase databases,which was verified by dual luciferase reporter assay.The expression level of STK17B protein in each group was detected by Western blot.Results The expression level of miR-628-3p was low in OV tissues,and the disease-free survival(DFS)was short in patients.Compared with miR-NC group,the miR-628-3p expression was up-regulated in both SKOV3 and HO8910 cells of miR-628-3p group(t=7.789 and 7.862,respectively,each P<0.05),the activity(t=8.124 and 8.209,respectively,each P<0.05),numbers(t=9.012 and 9.110,respectively,each P<0.05),migration(t=10.002 and 9.983,respectively,each P<0.05)and invasion(t=11.245 and 11.320,respectively,each P<0.05)abilities of OV cells were significantly decreased.Com-pared with miR-NC group,the volume and mass of transplanted tumors were significantly reduced in miR-628-3p group(t=8.429 and 10.367,respectively,each P<0.05).It was predicted by databases that STK17B was the target gene of miR-628-3p,which was verified by dual luciferase reporter assay.The levels of STK17B mRNA(t=13.852 and 13.914,respectively,each P<0.05)and protein(t=11.524 and 11.603,respectively,each P<0.05)in miR-628-3p group were lower than those in miR-NC group.GEPIA data analysis showed that STK17B was highly expressed in OV tissues.Compared with miR-628-3p group,the activity(t=8.692 and 8.721,respectively,each P<0.05),numbers(t=14.112 and 14.093,respectively,each P<0.05),migration(t=13.805 and 13.911,respectively,each P<0.05)and inva-sion(t=14.117 and 14.207,respectively,each P<0.05)abilities of SKOV3 and HO8910 cells significantly increased in miR-628-3p+STK17B group.Conclusion The miR-628-3p inhibits the proliferation,migration and invasion of OV cells by down-regulating STK17B expression,thereby inhibiting the development of OV.

miR-628-3pSerine/threonine kinase 17B(STK17B)Ovarian cancer(OV)Cell proliferationCell migra-tionCell invasion

姚慧欣、高丹、李化敏、杨冰、王悦宁、李会影、孙喆、柳菲菲

展开 >

牡丹江医学院附属红旗医院,黑龙江牡丹江 157011

miR-628-3p 丝氨酸/苏氨酸激酶17B 卵巢癌 细胞增殖 细胞迁移 细胞侵袭

黑龙江省省属高等学校基本科研业务费科研项目(2018)

2018-KYYWFMY-0079

2024

中国生物制品学杂志
中华预防医学会,长春生物制品研究所有限责任公司

中国生物制品学杂志

CSTPCD
影响因子:0.417
ISSN:1004-5503
年,卷(期):2024.37(4)
  • 25